Midday movers: Oracle, Apple, United Parcel Service and more

September 13, 2023 03:14 AM AEST | By Investing

Google News:

Midday movers: Oracle, Apple, United Parcel Service and more — Image source: Kalkine Media

Recent News

Fed Daly eyes fall for possible policy shift

Fifth Third Announces Three-Year, $20M Investment in North Nashville

Inogen Alliance Associate Awards: Environment Analyst Sustainability D...

New Zealand Construction Report 2025: Output to Contract by 1% Due to...

Investing.com -- U.S. stocks were mixed, with tech stocks falling after Oracle offered a disappointing outlook for the current quarter and as investors await more inflation data during the week to assess the possibility of more Federal Reserve rate hikes this year.

Here are some of the biggest U.S. stock movers today:

Oracle (NYSE:ORCL) stock fell 12.9% after the computer software company disappointed with its current-quarter revenue guidance, with the firm attributing this to the accelerated transition of its recent acquisition Cerner (NASDAQ:CERN) to the cloud.
Apple (NASDAQ:AAPL) stock fell 1.2% as the iPhone maker kicked off its latest hardware update in California, an event that is expected launch the iPhone 15.
Boeing (NYSE:BA) stock was flat after SMBC Aviation Capital, the world's second largest aircraft leasing firm, said it had concluded an order for 25 Boeing 737 MAX aircraft in a deal worth more than $3.7 billion at current list prices.
Geron (NASDAQ:GERN) stock fell 1.1% after Goldman Sachs (NYSE:GS) upgraded its stance to ‘buy’ from ‘neutral’, citing the potential for the company’s new drug application for imetelstat, aimed at treating lower-risk MDS.
WestRock (NYSE:WRK) stock jumped 3.4% after the company agreed to merge with Smurfit Kappa (LON:SKG), to create the world's largest listed paper and packaging company worth nearly $20 billion.
United Parcel Service (NYSE:UPS) stock fell 2.2% after the delivery giant stated that its new five-year contract covering some 340,000 Teamsters-represented workers in the United States would increase wage and benefit costs at a 3.3% compound annual growth rate over the life of the agreement.
Acelyrin (NASDAQ:SLRN) stock slumped over 58% after the drug maker’s experimental lead drug failed to show it was effective enough in reducing symptoms of an inflammatory skin disease.
Sight Sciences (NASDAQ:SGHT) stock fell over 47% after the manufacturer of ophthalmology surgical devices cut its revenue outlook, citing uncertainty about the future of Medicare coverage for its products.

-- Peter Nurse contributed to this report

This article first appeared in Investing.com

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.